Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer's disease neuroimaging initiative database.

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Journal of Neurological Sciences

• Publication date

  2020-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jns.2020.116829PMID 32289574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dementia is not synonymous with Alzheimer’s disease

  2019cited by this paper
• Innate immune activation in Alzheimer's disease.

  2018cited by this paper
• Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

  2018cited by this paper
• NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease

  2018cited by this paper
• IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis

  2018cited by this paper
• Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5

  2017cited by this paper
• A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer’s Disease Brains

  2017cited by this paper
• Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias

  2017cited by this paper
• Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuro-pathological Hallmarks

  2017cited by this paper
• A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease

  2016cited by this paper
• The role of interleukin-6 signaling in nervous tissue.

  2016cited by this paper
• C-reactive protein response to a vegan lifestyle intervention.

  2015cited by this paper
• Neuroinflammation in Lewy body dementia.

  2015cited by this paper
• Neuroinflammation in Alzheimer's disease.

  2015cited by this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014cited by this paper
• The Link Between C-Reactive Protein and Alzheimer's Disease Among Mexican Americans

  2013cited by this paper
• The global prevalence of dementia: A systematic review and metaanalysis

  2013cited by this paper
• Inflammatory process in Alzheimer's Disease

  2013cited by this paper
• APOE ε4 increases risk for dementia in pure synucleinopathies.

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

  2012cited by this paper
• Interleukin-6, a mental cytokine.

  2011cited by this paper
• Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

  2011cited by this paper
• Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

  2011cited by this paper
• Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

  2010cited by this paper
• Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition

  2010cited by this paper
• A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T)

  2010cited by this paper
• Fully-Automated White Matter Hyperintensity Detection with Anatomical Prior Knowledge and without FLAIR

  2009cited by this paper
• Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells1

  2008cited by this paper
• Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.

  2007cited by this paper
• Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

  2006cited by this paper
• Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?

  2005cited by this paper
• C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study

  2005cited by this paper
• Serum inflammatory proteins and cognitive decline in older persons

  2005cited by this paper
• The Alzheimer's disease neuroimaging initiative.

  2005cited by this paper
• Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.

  2003cited by this paper
• Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease

  2003cited by this paper
• Combination of serum markers related to several mechanisms in Alzheimer's disease.

  2003cited by this paper
• Interleukin-6, β-amyloid peptide and NMDA interactions in rat cortical neurons

  2003cited by this paper
• Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells.

  2002cited by this paper
• Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging

  2002cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Increased Soluble Tumor Necrosis Factor Receptor Levels in the Serum of Elderly People

  2000cited by this paper
• Interleukin‐16

  2000cited by this paper
• Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

  1998cited by this paper
• Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.

  1998cited by this paper
• Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.

  1998cited by this paper
• Serum interleukin‐6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

  1997cited by this paper
• The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

  1996cited by this paper
• Apolipoprotein E element 4 association with dementia in a population-based study

  1996cited by this paper
• IL‐6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage

  1995cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  1993cited by this paper

• Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum

  2025cites this paper
• Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

  2025cites this paper
• “Let's talk about sex, inflammaging, and cognition, baby”: A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease

  2024cites this paper
• Regional changes in brain metabolism during the progression of mild cognitive impairment: a longitudinal study based on radiomics

  2024influential citation
• CSF inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer’s disease spectrum

  2024cites this paper
• Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status

  2023cites this paper
• Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.

  2022cites this paper
• Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.

  2021cites this paper